1.Healthy adults 2.Parkinson'
Conditions
Interventions
None listed
Sponsors
Kao Corporation
Juntendo University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (The criteria for healthy subjects) 1.Panelists without neurodegenerative diseases. 2.Panelists who agree to have their typical daily routines. 3.Panelists who don't require assistance to participate in this trial. Panelists who don't require the legally acceptable representatives. (The criteria for subjects with Parkinson's disease and related diseases) 1.Panelists with Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, or normal pressure hydrocephalus. 2.Panelists who agree to have their typical daily routines.
Exclusion criteria
Exclusion criteria: 1.Panelists who have the type I or II diabetes. 2.Panelists who have the malignant tumors. 3.Panelists who have the skin diseases, such as atopic dermatitis, acne vulgaris, and psoriasis vulgaris. 4.Panelists who have the infectious diseases, such as HIV, HCV, HIV, and syphilis. 5.Panelists who use the antibiotics within 2 weeks before participation in this study. 6.Panelists who use the prescription drugs having any effects to this study. 7.Panelists who use the prescription topical agents on the face 8.Panelists who is considered as inappropriate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The differences of skin molecules between healthy subjects, subjects with Parkinson's disease, and subjects with related diseases. | — |
Secondary
| Measure | Time frame |
|---|---|
| The differences of blood components between healthy subjects, subjects with Parkinson's disease, and subjects with related diseases. The relationship of the molecules between skin and blood. | — |
Countries
Japan
Contacts
Public ContactYuya Uehara
Kao Corporation Biological Science Research
Outcome results
None listed